Sonos Inc: Form 10-Q for the period ended Jul 1, 2023
Filed with the SEC on Aug 10, 2023 and accepted by EDGAR at Aug 9, 2023, 19:51 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-02 to 2023-07-01 | $373.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-10-02 to 2023-07-01 | $1.35bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-04-02 to 2023-07-01 | $201.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-10-02 to 2023-07-01 | $761.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-04-02 to 2023-07-01 | $171.8m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-10-02 to 2023-07-01 | $588.4m | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-02 to 2023-07-01 | $77.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-10-02 to 2023-07-01 | $235.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-04-02 to 2023-07-01 | −$21.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-10-02 to 2023-07-01 | $7.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-04-02 to 2023-07-01 | $274.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2022-10-02 to 2023-07-01 | $585.0k | us-gaap:InterestExpense |
| Income tax | 3 months2023-04-02 to 2023-07-01 | $5.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-10-02 to 2023-07-01 | $16.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-02 to 2023-07-01 | −$23.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-10-02 to 2023-07-01 | $21.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-02 to 2023-07-01 | −$0.18 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-10-02 to 2023-07-01 | $0.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-02 to 2023-07-01 | −$0.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-10-02 to 2023-07-01 | $0.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-02 to 2023-07-01 | 128,311,109 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-10-02 to 2023-07-01 | 132,851,379 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-10-02 to 2023-07-01 | $78.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-10-02 to 2023-07-01 | $40.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2022-10-02 to 2023-07-01 | $45.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-01 | $268.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-01 | $708.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-01 | $1.07bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-01 | $344.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-01 | $475.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-07-01 | $590.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-040849. Last ingested by Listed: Oct 30, 2026, 12:37 ET. Listed shows no prices and gives no investment advice.